Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : LastShadow's Position Trading -- Ignore unavailable to you. Want to Upgrade?

To: tom pope who wrote (6420)	1/14/1999 4:19:00 PM
From: Mao II	Read Replies (1) \| Respond to of 43080

Tom: I feel your pain. It's interesting about the little biotechs. I have a small position in HIV, also up on earnings. Strike that. Not earnings; rather on smaller loss than last time around. And with a decent -- if not overwhelming -- supply of cash, which the company uses very cautiously, maybe too cautiously. I think what we may be seeing is a realization that a lot of these companies are NOT going to fall into the pits tomorrow. The well-managed ones will survive (in the face of turmoil in the money markets) and in the case of companies with promising lines of research, the value potential is still there. Could this be a good opportunity to move in to some longish positions in promising smaller biotechs? The last three or four months has brought a lot of them down. By the way, I played BLSI last summer for a small loss. Regards, M2 PS: ENMD closed like a friggin rocket today. Must be the human trials, don't you think? On the other side of the coin, I have a very long term position in WFMI which got slammed on earnings warning. Sigh. Picked up a little more tho (and now that's down).